Chinese english Germany Japanese Korea

GSK461364

GSK461364 Struktur
929095-18-1
CAS-Nr.
929095-18-1
Englisch Name:
GSK461364
Synonyma:
CS-553;GSK4613;GSK461364;GSK-461364;GSK-461364A;GSK461364 USP/EP/BP;GSK461364(GSK-461364);GSK-461364; GSK-461364A;PLK1 inhibitor GS461364;PLK1 inhibitor GSK461364
CBNumber:
CB62473747
Summenformel:
C27H28F3N5O2S
Molgewicht:
543.6
MOL-Datei:
929095-18-1.mol
Request For Quotation

GSK461364 Eigenschaften

Schmelzpunkt:
>150°C (dec.)
Siedepunkt:
658.0±65.0 °C(Predicted)
Dichte
1.39
storage temp. 
Hygroscopic, -20°C Freezer, Under inert atmosphere
Löslichkeit
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka
15.16±0.50(Predicted)
Aggregatzustand
Solid
Farbe
Off-White to Light Beige

Sicherheit

GSK461364 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

GSK 461364 is a dose-dependant inhibitor of proliferating cancer cell lines as well as an apoptotic agent at higher dosage levels.

GSK461364 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

GSK461364 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 116)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED 		+undefined-21-51877795
ivan@atkchemical.com China 32686 60
Hubei xin bonus chemical co. LTD 		86-13657291602
linda@hubeijusheng.com CHINA 22968 58
BOC Sciences 		+1-631-485-4226
inquiry@bocsci.com United States 19553 58
Alchem Pharmtech,Inc. 		8485655694
sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED 		+8618523575427
 sales@conier.com China 49391 58
career henan chemical co 		+86-0371-86658258 15093356674;
 factory@coreychem.com China 29826 58
ANHUI WITOP BIOTECH CO., LTD 		+8615255079626
 eric@witopchemical.com China 23556 58
Dideu Industries Group Limited 		+86-29-89586680 +86-15129568250
 1026@dideu.com China 28251 58
Finetech Industry Limited 		+86-27-87465837 +8618971612321
 info@finetechnology-ind.com China 9634 58
Hefei Hirisun Pharmatech Co., Ltd 		+8615056975894
 shawn@hirisunpharm.com CHINA 9923 58
  • (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide
  • GSK-461364A
  • GSK461364(GSK-461364)
  • 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]
  • 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phen
  • GSK461364
  • GSK-461364
  • GSK4613
  • 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide
  • GSK461364, 98%, a potent Polo-like kinase 1 (PLK1) inhibitor
  • GSK-461364; GSK-461364A
  • PLK1 inhibitor GS461364
  • CS-553
  • 2-Thiophenecarboxamide, 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-
  • GSK461364 USP/EP/BP
  • PLK1 inhibitor GSK461364
  • 5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide
  • 929095-18-1
  • C27H28F3N5O2S
  • Inhibitors
  • APIs
Copyright 2019 © ChemicalBook. All rights reserved